Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had ...

A passion for learning took her from apartheid South Africa to a beer brewery to becoming a healthcare consultant, all before ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Here is why it could be a smart buy now. Not every stock needs to be a millionaire-maker. Sometimes, slow and steady can win ...

Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Thousands of people were laid off Tuesday at the United States' top health agencies. Here are what positions and efforts were ...

The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine.  The decision had ...

The FDA, which typically handles medication access changes, hasn’t approved ivermectin to treat or prevent COVID-19.

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...